References
Orsolini G, Mastropaolo F, Favaro E, Piccinelli A, Bertelle D, Viapiana O, Rossini M, Bixio R (2023) Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus. Clin Rheumatol. https://doi.org/10.1007/s10067-023-06635-3
Corzo Garcia P, Garcia-Duitama I, Claramunt AA, Duran Jordà X, Monfort J, Salman-Monte TC (2023) Musculoskeletal involvement in systemic lupus erythematosus: a contrast-enhanced magnetic resonance imaging study in 107 subjects. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/kead223
Ceccarelli F, Cipriano E, Natalucci F et al (2020) Belimumab is able to induce a significant improvement of joint activity status in patients diagnosed with systemic lupus erythematosus: results from a 12-month longitudinal study. Isr Med Assoc 22:415–419
Mahmoud K, Zayat AS, Yusof Y et al (2019) Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus. Rheumatol 58:1353–1360. https://doi.org/10.1093/rheumatology/key422
Ceccarelli F, Natalucci F, Pirone C et al (2022) Erosive arthritis in systemic lupus erythematosus: application of cluster analysis. Clin Exp Rheumatol 40:2175–2178. https://doi.org/10.55563/clinexprheumatol/b8gaty
Iaccarino L, Andreoli L, Bocci EB et al (2018) Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study. J Autoimmun 86:1–8. https://doi.org/10.1016/j.jaut.2017.09.004
Ceccarelli F, Natalucci F, Olivieri G et al (2021) Erosive arthritis in systemic lupus erythematosus: not only Rhupus. Lupus 30:2029–2041. https://doi.org/10.1177/09612033211051637
Sandler RD, Vital EM, Mahmoud K, Prabu A, Riddell C, Teh LS, Edwards CJ, Yee CS (2023) Revision to the musculoskeletal domain of the BILAG-2004 index to incorporate ultrasound findings. Rheumatology (Oxford):kead241. https://doi.org/10.1093/rheumatology/kead241
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: R.B. reports personal fees from GSK outside the submitted work. F.M. does not have conflicts of interest for this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mastropaolo, F., Bixio, R. Joint erosions as potential disease subset identifier in systemic lupus erythematosus. Correspondence on: Role of ultrasound and magnetic resonance imaging in systemic lupus erythematosus erosive arthritis treatment response prediction. Clin Rheumatol 42, 2527–2528 (2023). https://doi.org/10.1007/s10067-023-06715-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-023-06715-4